- CN10 – The Cutaneous Melanoma Epidemic – Is it Real or an Artifact of Aggressive Diagnosis?
- CN11 – Global Dermatology in 2025 – Innovative Expensive Treatments for a Few Versus Low-cost Medications for Everyone?
- CO19 – Emergency Room Dermatology
- CO20 – Liposuction, Non-Invasive Fat Reduction, and Lipotransfer
- GC05-A: Global Celebration Forum
- GC05-B: Global Celebration Forum
- GC05-C: Global Celebration Forum
- PL05 – Plenary Session #5
- SY62 – Facial Rejuvenation – Fillers and Toxins
- SY63 – Occupational Dermatoses
- SY64 – Pruritus and Neuralgias
- SY65 – Parasitic Infections with Mucocutaneous Manifestations
- SY66 – Ethnic Skin and Hair
- SY67 – Recent Advances in Dermatopathology
- SY68 – Life-threatening Drug Reactions
- SY69 – Panniculitis
- SY70 – Men’s Issues
- SY71 – Tropical Dermatoses – from Established to Emerging
- SY72 – Drugs in the Pipeline – From Small Molecules to Antibodies
- SY73 – Medical Therapy – an Update
- SY74 – Cutaneous Side Effects of New Drugs
- WS70 – Cicatricial Alopecias
- WS71 – Microscopically Controlled (Mohs) Surgery
- WS72 – Advanced Laser Therapy
- WS73 – Behçet’s disease
- WS74 – Infections – Impact of Migrations & Travel
- WS75 – Porphyrias
- WS76 – Geriatric Dermatology
- WS78 – Photopheresis, Plasmapheresis and Immunoapheresis
- WS79 – Quality of Life and Disability in Dermatology
- WS80 – Flaps and Grafts
- WS81 – Inherited Tumor Syndromes
- WS82 – Stem Cells in Dermatology
- WS83 – The Role of H&E vs Immunohistochemistry